#USA #Healthcare Marketing #Short Hills, NJ #Doceree #Clinical Intent

Doceree Unveils Clinical Intent Signals for Healthcare Marketing

In a remarkable step towards modernizing healthcare marketing, Doceree has announced the launch of Clinical Intent Signals (CIS), marking a significant breakthrough for how life science marketers engage healthcare professionals (HCPs). This innovative tool is set to redefine the landscape of omnichannel healthcare marketing by providing a real-time intelligence layer that detects, interprets, and activates clinical intent based on the behavioral signals from HCPs. With the public launch scheduled for July 14, 2026, through the Daily Command Marketplace, this new service aims to enhance the prescription journey from physician awareness directly to the point of filling prescriptions.

A Shift from Static to Dynamic Engagement

The introduction of CIS means that marketers can now move beyond traditional methods that relied on static segmentation and retrospective analytics. Instead, they can directly connect with HCPs when their clinical decision-making is actively taking shape. By analyzing the digital footprint left by HCPs—such as searches, guideline references, and peer content consumption—CIS transforms these signals into actionable insights. This approach allows marketing strategies to align closely with individual clinical workflows, enabling timely and relevant engagements that resonate with HCP needs.

How Clinical Intent Signals Works

CIS operates on a privacy-first and compliant architecture that respects personal health information (PHI). It provides verified signals derived from HCP-level data—not patient data—ensuring adherence to industry standards. This technology empowers healthcare marketers to:

• - Harness a Unified Signal: Activate cohesive marketing efforts across multiple channels, including paid media, email, and patient support programs.
• - Predict Market Trends: Identify emerging intent weeks ahead of when traditional prescribing data becomes available, allowing for proactive engagement.
• - Match Messaging with Context: Align creative content and communication frequency to correspond accurately with where the HCP is in the decision process.
• - Optimize Audience Reach: Utilize real-time clinical context to refine audience targeting and expand outreach effectively.

This intent-based framework represents a meaningful shift from the conventional audience-based marketing approach. For the first time in healthcare marketing, strategies can adapt to the real-time behavioral signals of HCPs, which was previously hindered by fragmented data sources.

Pilot Program Results Validate Effectiveness

Doceree conducted a comprehensive pilot program with 36,000 matched HCPs across various therapeutic areas to validate the effectiveness of CIS. The results showcased:

• - A 38% faster progression through the HCP decision-making journey.
• - A 27% increase in engagement in context compared to control groups.
• - A 21% boost in media efficiency, indicating that campaigns driven by this new signal are more effective.

These findings illustrate how synchronizing marketing activations with clinical workflows can significantly improve engagement metrics, demonstrating that a respected clinician's path to prescribing can effectively inform marketing strategies.

Industry Recognition and Future Directions

Doceree's innovative approach has not gone unnoticed, as they received the Frost & Sullivan Global Technology Innovation Leadership Recognition. This accolade emphasizes Doceree's role in creating real-time clinical intent as a new normative standard in healthcare marketing, showcasing their capability to mobilize intent across the entire marketing spectrum.

Harshit Jain, MD, Founder and Global CEO of Doceree, emphasized the transformative nature of CIS: "For two decades, healthcare marketing has been built on what HCPs prescribed yesterday. Clinical Intent Signals lets us engage with what they are deciding today." This assertion underscores the importance of recognizing the dynamic nature of clinical decision-making in the marketing process.

Availability and Future Impact

As Clinical Intent Signals becomes available through the Daily Command Marketplace, life sciences companies, agencies, and marketers now have the opportunity to access sophisticated tools for navigating the evolving healthcare landscape. Packed with integrations for leading marketing platforms and available through various subscription models, CIS is poised to become an indispensable resource for healthcare marketers.

For additional information and insights, visit Doceree's official website.

In summary, with the launch of Clinical Intent Signals, Doceree is set not just to influence healthcare marketing but to revolutionize it, ultimately enhancing the connection between clinicians and the pharmaceutical brands that support them.